The abstract is read at the publisher; the summary is JClub's.
Non-phosphorylated AKT1 at Thr308 licenses SQSTM1-LC3C-mediated antiviral autophagy, enabling selective degradation of viral capsids in an HSP90AA1-driven pathway.
- Why it matters: The study addresses how AKT1 can function beyond its kinase role during antiviral defense, and how viral recognition is translated into autophagy targeting.
- What they did: Membrane-associated HSP90AA1 disrupts the HSP90–AKT1 interaction upon dsRNA viral capsid recognition, inducing AKT1 Thr308 dephosphorylation; this recruits PDPK1 and SQSTM1 to promote SQSTM1 Ser349 phosphorylation and LC3C-positive phagophore loading.
- The result: An IBDV capsid mutant defective in SQSTM1 binding escapes the pathway, and in vivo non-phosphorylatable AKT1 suppresses rotavirus replication in a SQSTM1-dependent manner.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.